Catheter Precision (VTAK) Share-based Compensation (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143.84% |
| Dec 31, 2025 | 12.86% |
| Sep 30, 2025 | -28.57% |
| Jun 30, 2025 | 7.69% |
| Mar 31, 2025 | 405.56% |
| Dec 31, 2024 | 5.88% |
| Sep 30, 2024 | 30.77% |
| Jun 30, 2024 | 116.67% |
| Mar 31, 2024 | 220.00% |
| Dec 31, 2023 | -350.00% |
| Sep 30, 2023 | -98.85% |
| Jun 30, 2023 | -87.52% |
| Mar 31, 2023 | 1,484.09% |
| Dec 31, 2022 | 18.92% |
| Sep 30, 2022 | -39.84% |
| Jun 30, 2022 | -25.45% |
| Mar 31, 2022 | 89.66% |
| Dec 31, 2021 | 1,640.00% |
| Sep 30, 2021 | -99.21% |
| Jun 30, 2021 | -45.59% |
| Mar 31, 2021 | -12.83% |
| Dec 31, 2020 | 53.78% |
| Sep 30, 2020 | -7.82% |
| Jun 30, 2020 | -9.65% |
| Mar 31, 2020 | 565.33% |
| Dec 31, 2019 | -103.28% |
| Sep 30, 2019 | 3.27% |
| Jun 30, 2019 | -8.15% |
| Mar 31, 2019 | -14.02% |
| Dec 31, 2018 | 478.66% |
| Sep 30, 2018 | -67.12% |
| Jun 30, 2018 | 743.32% |
| Mar 31, 2018 | -54.91% |
| Dec 31, 2017 | 104.22% |